Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Mineralys Therapeutics Inc (MLYS)

  • SEC News
  • July 31, 2025, 00:12 UTC
  • 1

New Form 4 - Mineralys Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001933414-25-000081 Size: 10 KB

Comment Full text

Standard Biotools Inc (LAB)

  • SEC News
  • July 31, 2025, 00:11 UTC
  • 0

New Form 4/A - STANDARD BIOTOOLS INC. Filed: 2025-07-30 AccNo: 0000950170-25-100490 Size: 4 KB

Comment Full text

Tilray Brands Inc. (TLRY)

  • SEC News
  • July 30, 2025, 22:53 UTC
  • 0

New Form 4 - Tilray Brands, Inc. Filed: 2025-07-30 AccNo: 0001171843-25-004845 Size: 5 KB

Comment Full text

Nurix Therapeutics Inc (NRIX)

  • SEC News
  • July 30, 2025, 22:50 UTC
  • 0

New Form 4 - Nurix Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001549595-25-000101 Size: 21 KB

Comment Full text

Nurix Therapeutics Inc (NRIX)

  • SEC News
  • July 30, 2025, 22:49 UTC
  • 0

New Form 4 - Nurix Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001549595-25-000099 Size: 21 KB

Comment Full text

Nurix Therapeutics Inc (NRIX)

  • SEC News
  • July 30, 2025, 22:49 UTC
  • 0

New Form 4 - Nurix Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001549595-25-000100 Size: 21 KB

Comment Full text

Adaptimmune Therapeutics plc (ADAP)

  • SEC News
  • July 30, 2025, 22:21 UTC
  • 0

New Form 4 - Adaptimmune Therapeutics PLC Filed: 2025-07-30 AccNo: 0000935836-25-000476 Size: 11 KB

Comment Full text

IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)

  • SEC News
  • July 30, 2025, 21:58 UTC
  • 0

New Form 4 - Enliven Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0001415889-25-020605 Size: 11 KB

Comment Full text

Immunovant Inc (IMVT)

  • SEC News
  • July 30, 2025, 21:57 UTC
  • 0

New Form 4 - Immunovant, Inc. Filed: 2025-07-30 AccNo: 0001764013-25-000124 Size: 19 KB

Comment Full text

Sage Therapeutics Inc (SAGE)

  • SEC News
  • July 30, 2025, 21:57 UTC
  • 0

New Form SCHEDULE 13D/A - Sage Therapeutics, Inc. Filed: 2025-07-30 AccNo: 0000950157-25-000596 Size: 7 KB

Comment Full text
  • Previous
  • 48
  • 49
  • 50
  • 51
  • 52
  • Next

Search

News categories

  • Technical Exchange News(9696)
  • Event(407)
  • SEC News(159514)
  • FDA Approval(9149)
  • Company Report(721)
  • Business News(108457)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin